Theseus Pharmaceuticals Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2015	FY 2014
Period Ending	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Revenue	6,511	5,014
Revenue Growth (YoY)	29.86%	-
Cost of Revenue	3,537	2,496
Gross Profit	2,974	2,518
Selling, General & Admin	2,446	1,899
Research & Development	478.13	548.27
Other Operating Expenses	7.05	7.63
Operating Expenses	3,266	2,506
Operating Income	-291.09	11.81
Interest Expense	-110.46	-127.19
Interest & Investment Income	52.72	64.45
Currency Exchange Gain (Loss)	14.64	12.87
Other Non Operating Income (Expenses)	53	88.33
EBT Excluding Unusual Items	-281.18	50.26
Gain (Loss) on Sale of Investments	-7.23	2.1
Gain (Loss) on Sale of Assets	0.89	-
Pretax Income	-287.52	52.36
Income Tax Expense	1.37	26.96
Net Income	-288.89	25.4
Net Income to Common	-288.89	25.4
Shares Outstanding (Basic)	0	0
Shares Outstanding (Diluted)	0	0
Shares Change (YoY)	0.01%	-
EPS (Basic)	-2889.02	254.00
EPS (Diluted)	-2889.02	254.00
Free Cash Flow	139.25	335.45
Free Cash Flow Per Share	1392.53	3354.73
Gross Margin	45.68%	50.21%
Operating Margin	-4.47%	0.24%
Profit Margin	-4.44%	0.51%
Free Cash Flow Margin	2.14%	6.69%
EBITDA	183.53	226.89
EBITDA Margin	2.82%	4.52%
D&A For EBITDA	474.62	215.08
EBIT	-291.09	11.81
EBIT Margin	-4.47%	0.24%
Effective Tax Rate	-	51.49%
Advertising Expenses	92.21	105.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.